This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1985 May 16;312(20):1300-10.

doi: 10.1056/NEJM198505163122007.

Pathogenesis and management of lipoprotein disorders

E J Schaefer, R I Levy

PMID: 3887163
DOI: 10.1056/NEJM198505163122007

Review

Pathogenesis and management of lipoprotein disorders

E J Schaefer et al. N Engl J Med. 1985.

. 1985 May 16;312(20):1300-10.

doi: 10.1056/NEJM198505163122007.

Authors

E J Schaefer, R I Levy

PMID: 3887163
DOI: 10.1056/NEJM198505163122007

No abstract available

PubMed Disclaimer

Similar articles

The diagnosis and management of hyperlipidemia.
Gotto AM Jr, Jones PH, Scott LW. Gotto AM Jr, et al. Dis Mon. 1986 May;32(5):245-311. doi: 10.1016/s0011-5029(86)80011-6. Dis Mon. 1986. PMID: 3519132 Review. No abstract available.
The hyperlipoproteinemias.
Whayne TF Jr. Whayne TF Jr. J Fam Pract. 1980 Nov;11(5):789-99. J Fam Pract. 1980. PMID: 7430980 No abstract available.
Therapy of hyperlipidemic states.
Havel RJ, Kane JP. Havel RJ, et al. Annu Rev Med. 1982;33:417-33. doi: 10.1146/annurev.me.33.020182.002221. Annu Rev Med. 1982. PMID: 7044276 Review. No abstract available.
Rational drug therapy of the hyperlipoproteinemias, Part II.
Blum CB, Levy RI. Blum CB, et al. Ration Drug Ther. 1986 Oct;20(10):1-4. Ration Drug Ther. 1986. PMID: 3472266 No abstract available.
[Arteriosclerosis. III. Laboratory diagnosis of dyslipoproteinemia].
Nowicka G, Kłosiewicz-Latoszek L. Nowicka G, et al. Wiad Lek. 1985 Aug 15;38(16):1179-84. Wiad Lek. 1985. PMID: 4082589 Polish. No abstract available.

See all similar articles

Cited by

The evaluation and treatment of hypercholesterolemia in primary care practice.
Peters WL, Goroll AH. Peters WL, et al. J Gen Intern Med. 1986 May-Jun;1(3):183-95. doi: 10.1007/BF02602336. J Gen Intern Med. 1986. PMID: 3534173 Review. No abstract available.
How well tolerated are lipid-lowering drugs?
Tomlinson B, Chan P, Lan W. Tomlinson B, et al. Drugs Aging. 2001;18(9):665-83. doi: 10.2165/00002512-200118090-00003. Drugs Aging. 2001. PMID: 11599634 Review.
Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases.
Chardon L, Sassolas A, Dingeon B, Michel-Calemard L, Bovier-Lapierre M, Moulin P, Lachaux A. Chardon L, et al. Eur J Pediatr. 2009 Aug;168(8):983-9. doi: 10.1007/s00431-008-0888-6. Epub 2008 Dec 9. Eur J Pediatr. 2009. PMID: 19066957
Atherosclerosis: the eicosanoid connection.
Makheja AN. Makheja AN. Mol Cell Biochem. 1992 Apr;111(1-2):137-42. doi: 10.1007/BF00229585. Mol Cell Biochem. 1992. PMID: 1588937 Review.
Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.
Buckley MM, Goa KL, Price AH, Brogden RN. Buckley MM, et al. Drugs. 1989 Jun;37(6):761-800. doi: 10.2165/00003495-198937060-00002. Drugs. 1989. PMID: 2667936 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov